Millie
your market intelligence analyst
Search Results
Edit Save
208,673 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
Telegeography CommsUpdate 10/30/2020 07:12
Brazilian B2B operator AmericaNet has reportedly trialled a fixed-wireless 5G solution with Nokia in Pindamonhangaba, Sao Paulo. According to TeleSintese, the test utilised spectrum in the 3.5GHz and 26GHz bands under temporary permits granted by the National Telecommunications Agency (Agencia Nacional de Telecomunicacoes, Anatel). The trial generated download speeds of 4Gbps, which is said to be a record for Latin America.
RosBusiness (Russian) 10/30/2020 07:06
Председатель Конституционного суда Украины заявил, что усматривает в законопроекте президента страны Владимира Зеленского, предусматривающего лишение действующих судей КС полномочий, «признаки конституционного переворота», передает издание «Лига».
Bitcoins Channel 10/30/2020 07:06
After purchasing a sizeable amount of bitcoins for himself and his company, Michael Saylor said that the firm he operates, MicroStrategy, has been running a full node of Bitcoin’s latest core version for over a month. MicroStrategy Runs A Full BTC Node Bitcoin nodes are an essential part of the Bitcoin blockchain peer-to-peer network. Running ... .
Science in the News 10/30/2020 07:05
How do you introduce yourself, scientifically? My name is Michael Miyagi, and I’m an evolutionary biologist, which means that I study how the process of evolution works and how that process has generated the incredible biodiversity that we have today. More specifically, I’m a theoretical population geneticist. Population genetics is how we think about evolution and variation across entire populations. In other words, how individuals …. .
ENDPOINTS 10/30/2020 07:04
Earlier this month, the small French biotech Inventiva themselves as having won the first FDA breakthrough designation in NASH since Intercept grabbed the first one back in 2015, before the disease had become one of biotech’s hottest areas. Unbeknownst to them, though, a much larger European rival had already landed the status months prior. Novo Nordisk, the Danish metabolic giant, in their Q3 report Friday that back in August, the FDA gave them breakthrough status for semaglutide, their blockbuster diabetes drug, in NASH, or non-alcoholic steatohepatitis. The designation sets Novo up as a leading contender in a new wave of companies developing treatments for a silent and widespread disease that, despite a series of , is still viewed by man.

Personal Care

Household Products

Business Issues

Trends

Companies - Public

Companies - Venture Funded

Information Technologies

Regions

Job Titles